Life Sciences Ontario perspectives on how CETA opens new pathways for Canadian innovation
LSO - CETA opens new pathways for Canadian innovation -- now we need to build on it - LSO News
The IP interventions ensconced in CETA, while most pertinent to the pharmaceutical industry, are relevant across the life sciences and tech sectors. Why? They signal a fundamental shift in how we approach innovation in a global context. CETA sends a strong message that Canada, as a country, is becoming more progressive and competitive.